Eric R. Fedyk

The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases

Dulce Soler, Tobias R. Chapman, Lili Yang et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 451 citations

IL-8 Production in Human Lung Fibroblasts and Epithelial Cells Activated by the <i>Pseudomonas</i> Autoinducer <i>N</i> -3-Oxododecanoyl Homoserine Lactone Is Transcriptionally Regulated by NF-κB and Activator Protein-2

Roger S. Smith, Eric R. Fedyk, T. Springer et al. · The Journal of Immunology · 2001 · 272 citations · Full text

Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells.

Eric R. Fedyk, RP Phipps · Proceedings of the National Academy of Sciences · 1996 · 151 citations · Full text

Lymphocyte Development, Immunology, Immune Regulation +18

CCR8 Expression Identifies CD4 Memory T Cells Enriched for FOXP3+ Regulatory and Th2 Effector Lymphocytes

Dulce Soler, Tobias R. Chapman, Louis Poisson et al. · The Journal of Immunology · 2006 · 139 citations · Full text

Foxp3+ Regulatory, T-regulatory Cell, Immunology +19

Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates

Eric R. Fedyk, Tim Wyant, Lili Yang et al. · Inflammatory Bowel Diseases · 2012 · 138 citations · Full text